nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—Cladribine—multiple sclerosis	0.132	0.187	CbGbCtD
Rabeprazole—ABCG2—Mitoxantrone—multiple sclerosis	0.0963	0.136	CbGbCtD
Rabeprazole—CYP2D6—Fingolimod—multiple sclerosis	0.0696	0.0983	CbGbCtD
Rabeprazole—ABCG2—Dexamethasone—multiple sclerosis	0.0499	0.0705	CbGbCtD
Rabeprazole—CYP1A1—Dexamethasone—multiple sclerosis	0.0461	0.0651	CbGbCtD
Rabeprazole—CYP3A4—Fingolimod—multiple sclerosis	0.0443	0.0625	CbGbCtD
Rabeprazole—ABCG2—Methotrexate—multiple sclerosis	0.0401	0.0567	CbGbCtD
Rabeprazole—CYP2C19—Prednisone—multiple sclerosis	0.0357	0.0505	CbGbCtD
Rabeprazole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0285	0.0403	CbGbCtD
Rabeprazole—CYP2C19—Dexamethasone—multiple sclerosis	0.0223	0.0315	CbGbCtD
Rabeprazole—CYP3A4—Triamcinolone—multiple sclerosis	0.0216	0.0305	CbGbCtD
Rabeprazole—CYP3A4—Mitoxantrone—multiple sclerosis	0.0208	0.0294	CbGbCtD
Rabeprazole—CYP2C9—Dexamethasone—multiple sclerosis	0.0186	0.0262	CbGbCtD
Rabeprazole—CYP3A4—Betamethasone—multiple sclerosis	0.0185	0.0262	CbGbCtD
Rabeprazole—CYP3A4—Prednisolone—multiple sclerosis	0.0183	0.0259	CbGbCtD
Rabeprazole—CYP3A4—Prednisone—multiple sclerosis	0.0173	0.0244	CbGbCtD
Rabeprazole—CYP2D6—Dexamethasone—multiple sclerosis	0.017	0.024	CbGbCtD
Rabeprazole—CYP3A4—Dexamethasone—multiple sclerosis	0.0108	0.0152	CbGbCtD
Rabeprazole—ABCG2—Irinotecan Pathway—BCHE—multiple sclerosis	0.000188	0.0313	CbGpPWpGaD
Rabeprazole—Stomatitis—Methotrexate—multiple sclerosis	0.00017	0.000593	CcSEcCtD
Rabeprazole—Angiopathy—Prednisone—multiple sclerosis	0.00017	0.000593	CcSEcCtD
Rabeprazole—Conjunctivitis—Methotrexate—multiple sclerosis	0.000169	0.000591	CcSEcCtD
Rabeprazole—Confusional state—Methylprednisolone—multiple sclerosis	0.000169	0.000591	CcSEcCtD
Rabeprazole—Malaise—Dexamethasone—multiple sclerosis	0.000169	0.000589	CcSEcCtD
Rabeprazole—Malaise—Betamethasone—multiple sclerosis	0.000169	0.000589	CcSEcCtD
Rabeprazole—Oedema—Triamcinolone—multiple sclerosis	0.000168	0.000587	CcSEcCtD
Rabeprazole—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000168	0.000587	CcSEcCtD
Rabeprazole—Vertigo—Dexamethasone—multiple sclerosis	0.000168	0.000587	CcSEcCtD
Rabeprazole—Vertigo—Betamethasone—multiple sclerosis	0.000168	0.000587	CcSEcCtD
Rabeprazole—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000168	0.000586	CcSEcCtD
Rabeprazole—Syncope—Dexamethasone—multiple sclerosis	0.000168	0.000586	CcSEcCtD
Rabeprazole—Syncope—Betamethasone—multiple sclerosis	0.000168	0.000586	CcSEcCtD
Rabeprazole—Arrhythmia—Prednisone—multiple sclerosis	0.000167	0.000584	CcSEcCtD
Rabeprazole—Sweating—Methotrexate—multiple sclerosis	0.000167	0.000583	CcSEcCtD
Rabeprazole—Haematuria—Methotrexate—multiple sclerosis	0.000166	0.00058	CcSEcCtD
Rabeprazole—Shock—Triamcinolone—multiple sclerosis	0.000165	0.000578	CcSEcCtD
Rabeprazole—Insomnia—Prednisolone—multiple sclerosis	0.000165	0.000578	CcSEcCtD
Rabeprazole—Alopecia—Prednisone—multiple sclerosis	0.000165	0.000577	CcSEcCtD
Rabeprazole—Shock—Methylprednisolone—multiple sclerosis	0.000165	0.000577	CcSEcCtD
Rabeprazole—ABCG2—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000165	0.0274	CbGpPWpGaD
Rabeprazole—Loss of consciousness—Betamethasone—multiple sclerosis	0.000164	0.000574	CcSEcCtD
Rabeprazole—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000164	0.000574	CcSEcCtD
Rabeprazole—Epistaxis—Methotrexate—multiple sclerosis	0.000164	0.000574	CcSEcCtD
Rabeprazole—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000164	0.000574	CcSEcCtD
Rabeprazole—Paraesthesia—Prednisolone—multiple sclerosis	0.000164	0.000574	CcSEcCtD
Rabeprazole—Tachycardia—Triamcinolone—multiple sclerosis	0.000164	0.000573	CcSEcCtD
Rabeprazole—Nausea—Azathioprine—multiple sclerosis	0.000164	0.000572	CcSEcCtD
Rabeprazole—Tachycardia—Methylprednisolone—multiple sclerosis	0.000164	0.000572	CcSEcCtD
Rabeprazole—Erythema—Prednisone—multiple sclerosis	0.000163	0.000569	CcSEcCtD
Rabeprazole—Malnutrition—Prednisone—multiple sclerosis	0.000163	0.000569	CcSEcCtD
Rabeprazole—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000163	0.000568	CcSEcCtD
Rabeprazole—Agranulocytosis—Methotrexate—multiple sclerosis	0.000162	0.000568	CcSEcCtD
Rabeprazole—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000162	0.000567	CcSEcCtD
Rabeprazole—Convulsion—Betamethasone—multiple sclerosis	0.000162	0.000566	CcSEcCtD
Rabeprazole—Convulsion—Dexamethasone—multiple sclerosis	0.000162	0.000566	CcSEcCtD
Rabeprazole—Hypertension—Betamethasone—multiple sclerosis	0.000161	0.000564	CcSEcCtD
Rabeprazole—Hypertension—Dexamethasone—multiple sclerosis	0.000161	0.000564	CcSEcCtD
Rabeprazole—Asthenia—Mitoxantrone—multiple sclerosis	0.00016	0.000559	CcSEcCtD
Rabeprazole—Myalgia—Betamethasone—multiple sclerosis	0.000159	0.000556	CcSEcCtD
Rabeprazole—Myalgia—Dexamethasone—multiple sclerosis	0.000159	0.000556	CcSEcCtD
Rabeprazole—Anxiety—Dexamethasone—multiple sclerosis	0.000159	0.000554	CcSEcCtD
Rabeprazole—Anxiety—Betamethasone—multiple sclerosis	0.000159	0.000554	CcSEcCtD
Rabeprazole—Discomfort—Betamethasone—multiple sclerosis	0.000157	0.000549	CcSEcCtD
Rabeprazole—Discomfort—Dexamethasone—multiple sclerosis	0.000157	0.000549	CcSEcCtD
Rabeprazole—Hypotension—Methylprednisolone—multiple sclerosis	0.000157	0.000548	CcSEcCtD
Rabeprazole—Pain—Prednisolone—multiple sclerosis	0.000156	0.000546	CcSEcCtD
Rabeprazole—Hepatitis—Methotrexate—multiple sclerosis	0.000156	0.000546	CcSEcCtD
Rabeprazole—Pharyngitis—Methotrexate—multiple sclerosis	0.000155	0.000542	CcSEcCtD
Rabeprazole—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000154	0.000539	CcSEcCtD
Rabeprazole—Vision blurred—Prednisone—multiple sclerosis	0.000153	0.000536	CcSEcCtD
Rabeprazole—Urethral disorder—Methotrexate—multiple sclerosis	0.000153	0.000535	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000153	0.000535	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000153	0.000534	CcSEcCtD
Rabeprazole—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000153	0.000533	CcSEcCtD
Rabeprazole—Oedema—Dexamethasone—multiple sclerosis	0.000153	0.000533	CcSEcCtD
Rabeprazole—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000153	0.000533	CcSEcCtD
Rabeprazole—Oedema—Betamethasone—multiple sclerosis	0.000153	0.000533	CcSEcCtD
Rabeprazole—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000152	0.000533	CcSEcCtD
Rabeprazole—Insomnia—Triamcinolone—multiple sclerosis	0.000152	0.000531	CcSEcCtD
Rabeprazole—Insomnia—Methylprednisolone—multiple sclerosis	0.000152	0.00053	CcSEcCtD
Rabeprazole—Ill-defined disorder—Prednisone—multiple sclerosis	0.000151	0.000528	CcSEcCtD
Rabeprazole—Paraesthesia—Triamcinolone—multiple sclerosis	0.000151	0.000528	CcSEcCtD
Rabeprazole—Feeling abnormal—Prednisolone—multiple sclerosis	0.000151	0.000526	CcSEcCtD
Rabeprazole—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000151	0.000526	CcSEcCtD
Rabeprazole—Visual impairment—Methotrexate—multiple sclerosis	0.000151	0.000526	CcSEcCtD
Rabeprazole—Anaemia—Prednisone—multiple sclerosis	0.00015	0.000526	CcSEcCtD
Rabeprazole—Shock—Betamethasone—multiple sclerosis	0.00015	0.000524	CcSEcCtD
Rabeprazole—Shock—Dexamethasone—multiple sclerosis	0.00015	0.000524	CcSEcCtD
Rabeprazole—Dyspnoea—Triamcinolone—multiple sclerosis	0.00015	0.000524	CcSEcCtD
Rabeprazole—Agitation—Prednisone—multiple sclerosis	0.00015	0.000523	CcSEcCtD
Rabeprazole—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000149	0.000522	CcSEcCtD
Rabeprazole—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000149	0.000522	CcSEcCtD
Rabeprazole—Tachycardia—Betamethasone—multiple sclerosis	0.000149	0.00052	CcSEcCtD
Rabeprazole—Tachycardia—Dexamethasone—multiple sclerosis	0.000149	0.00052	CcSEcCtD
Rabeprazole—Angioedema—Prednisone—multiple sclerosis	0.000149	0.00052	CcSEcCtD
Rabeprazole—Dyspepsia—Triamcinolone—multiple sclerosis	0.000148	0.000517	CcSEcCtD
Rabeprazole—Erythema multiforme—Methotrexate—multiple sclerosis	0.000148	0.000516	CcSEcCtD
Rabeprazole—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000148	0.000516	CcSEcCtD
Rabeprazole—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000147	0.000515	CcSEcCtD
Rabeprazole—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000147	0.000515	CcSEcCtD
Rabeprazole—Malaise—Prednisone—multiple sclerosis	0.000147	0.000513	CcSEcCtD
Rabeprazole—Vertigo—Prednisone—multiple sclerosis	0.000146	0.000511	CcSEcCtD
Rabeprazole—Eye disorder—Methotrexate—multiple sclerosis	0.000146	0.00051	CcSEcCtD
Rabeprazole—Syncope—Prednisone—multiple sclerosis	0.000146	0.00051	CcSEcCtD
Rabeprazole—Tinnitus—Methotrexate—multiple sclerosis	0.000146	0.000509	CcSEcCtD
Rabeprazole—Anorexia—Dexamethasone—multiple sclerosis	0.000145	0.000508	CcSEcCtD
Rabeprazole—Anorexia—Betamethasone—multiple sclerosis	0.000145	0.000508	CcSEcCtD
Rabeprazole—Urticaria—Prednisolone—multiple sclerosis	0.000145	0.000507	CcSEcCtD
Rabeprazole—Pain—Triamcinolone—multiple sclerosis	0.000144	0.000502	CcSEcCtD
Rabeprazole—Loss of consciousness—Prednisone—multiple sclerosis	0.000143	0.0005	CcSEcCtD
Rabeprazole—Hypotension—Dexamethasone—multiple sclerosis	0.000143	0.000498	CcSEcCtD
Rabeprazole—Hypotension—Betamethasone—multiple sclerosis	0.000143	0.000498	CcSEcCtD
Rabeprazole—Angiopathy—Methotrexate—multiple sclerosis	0.000142	0.000495	CcSEcCtD
Rabeprazole—Vomiting—Mitoxantrone—multiple sclerosis	0.000142	0.000495	CcSEcCtD
Rabeprazole—Convulsion—Prednisone—multiple sclerosis	0.000141	0.000493	CcSEcCtD
Rabeprazole—Hypertension—Prednisone—multiple sclerosis	0.000141	0.000491	CcSEcCtD
Rabeprazole—Rash—Mitoxantrone—multiple sclerosis	0.000141	0.000491	CcSEcCtD
Rabeprazole—Dermatitis—Mitoxantrone—multiple sclerosis	0.00014	0.000491	CcSEcCtD
Rabeprazole—Chills—Methotrexate—multiple sclerosis	0.00014	0.00049	CcSEcCtD
Rabeprazole—Headache—Mitoxantrone—multiple sclerosis	0.00014	0.000488	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000139	0.000486	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000139	0.000486	CcSEcCtD
Rabeprazole—Myalgia—Prednisone—multiple sclerosis	0.000139	0.000484	CcSEcCtD
Rabeprazole—Arthralgia—Prednisone—multiple sclerosis	0.000139	0.000484	CcSEcCtD
Rabeprazole—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000139	0.000484	CcSEcCtD
Rabeprazole—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000138	0.000483	CcSEcCtD
Rabeprazole—Anxiety—Prednisone—multiple sclerosis	0.000138	0.000483	CcSEcCtD
Rabeprazole—Alopecia—Methotrexate—multiple sclerosis	0.000138	0.000483	CcSEcCtD
Rabeprazole—Insomnia—Dexamethasone—multiple sclerosis	0.000138	0.000482	CcSEcCtD
Rabeprazole—Insomnia—Betamethasone—multiple sclerosis	0.000138	0.000482	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000137	0.000479	CcSEcCtD
Rabeprazole—Paraesthesia—Betamethasone—multiple sclerosis	0.000137	0.000479	CcSEcCtD
Rabeprazole—Paraesthesia—Dexamethasone—multiple sclerosis	0.000137	0.000479	CcSEcCtD
Rabeprazole—Discomfort—Prednisone—multiple sclerosis	0.000137	0.000478	CcSEcCtD
Rabeprazole—Erythema—Methotrexate—multiple sclerosis	0.000136	0.000475	CcSEcCtD
Rabeprazole—Malnutrition—Methotrexate—multiple sclerosis	0.000136	0.000475	CcSEcCtD
Rabeprazole—Hypersensitivity—Prednisolone—multiple sclerosis	0.000135	0.000471	CcSEcCtD
Rabeprazole—Dyspepsia—Dexamethasone—multiple sclerosis	0.000134	0.000469	CcSEcCtD
Rabeprazole—Dyspepsia—Betamethasone—multiple sclerosis	0.000134	0.000469	CcSEcCtD
Rabeprazole—Urticaria—Triamcinolone—multiple sclerosis	0.000134	0.000467	CcSEcCtD
Rabeprazole—Urticaria—Methylprednisolone—multiple sclerosis	0.000133	0.000466	CcSEcCtD
Rabeprazole—Dysgeusia—Methotrexate—multiple sclerosis	0.000133	0.000466	CcSEcCtD
Rabeprazole—Body temperature increased—Triamcinolone—multiple sclerosis	0.000133	0.000464	CcSEcCtD
Rabeprazole—Oedema—Prednisone—multiple sclerosis	0.000133	0.000464	CcSEcCtD
Rabeprazole—Anaphylactic shock—Prednisone—multiple sclerosis	0.000133	0.000464	CcSEcCtD
Rabeprazole—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000133	0.000463	CcSEcCtD
Rabeprazole—Decreased appetite—Dexamethasone—multiple sclerosis	0.000133	0.000463	CcSEcCtD
Rabeprazole—Decreased appetite—Betamethasone—multiple sclerosis	0.000133	0.000463	CcSEcCtD
Rabeprazole—Nausea—Mitoxantrone—multiple sclerosis	0.000132	0.000463	CcSEcCtD
Rabeprazole—Back pain—Methotrexate—multiple sclerosis	0.000132	0.00046	CcSEcCtD
Rabeprazole—Shock—Prednisone—multiple sclerosis	0.000131	0.000457	CcSEcCtD
Rabeprazole—Pain—Dexamethasone—multiple sclerosis	0.00013	0.000456	CcSEcCtD
Rabeprazole—Pain—Betamethasone—multiple sclerosis	0.00013	0.000456	CcSEcCtD
Rabeprazole—Tachycardia—Prednisone—multiple sclerosis	0.00013	0.000453	CcSEcCtD
Rabeprazole—Hyperhidrosis—Prednisone—multiple sclerosis	0.000128	0.000449	CcSEcCtD
Rabeprazole—Vision blurred—Methotrexate—multiple sclerosis	0.000128	0.000448	CcSEcCtD
Rabeprazole—Anorexia—Prednisone—multiple sclerosis	0.000127	0.000442	CcSEcCtD
Rabeprazole—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000126	0.000441	CcSEcCtD
Rabeprazole—Anaemia—Methotrexate—multiple sclerosis	0.000126	0.000439	CcSEcCtD
Rabeprazole—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000126	0.000439	CcSEcCtD
Rabeprazole—Feeling abnormal—Betamethasone—multiple sclerosis	0.000126	0.000439	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000125	0.000436	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000125	0.000436	CcSEcCtD
Rabeprazole—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000124	0.000433	CcSEcCtD
Rabeprazole—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000124	0.000432	CcSEcCtD
Rabeprazole—Malaise—Methotrexate—multiple sclerosis	0.000123	0.000429	CcSEcCtD
Rabeprazole—Vertigo—Methotrexate—multiple sclerosis	0.000122	0.000427	CcSEcCtD
Rabeprazole—Leukopenia—Methotrexate—multiple sclerosis	0.000122	0.000425	CcSEcCtD
Rabeprazole—Urticaria—Betamethasone—multiple sclerosis	0.000121	0.000423	CcSEcCtD
Rabeprazole—Urticaria—Dexamethasone—multiple sclerosis	0.000121	0.000423	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000121	0.000423	CcSEcCtD
Rabeprazole—Dizziness—Prednisolone—multiple sclerosis	0.000121	0.000422	CcSEcCtD
Rabeprazole—Asthenia—Triamcinolone—multiple sclerosis	0.000121	0.000421	CcSEcCtD
Rabeprazole—Body temperature increased—Betamethasone—multiple sclerosis	0.000121	0.000421	CcSEcCtD
Rabeprazole—Body temperature increased—Dexamethasone—multiple sclerosis	0.000121	0.000421	CcSEcCtD
Rabeprazole—Abdominal pain—Dexamethasone—multiple sclerosis	0.000121	0.000421	CcSEcCtD
Rabeprazole—Abdominal pain—Betamethasone—multiple sclerosis	0.000121	0.000421	CcSEcCtD
Rabeprazole—Asthenia—Methylprednisolone—multiple sclerosis	0.00012	0.000421	CcSEcCtD
Rabeprazole—Insomnia—Prednisone—multiple sclerosis	0.00012	0.00042	CcSEcCtD
Rabeprazole—Paraesthesia—Prednisone—multiple sclerosis	0.000119	0.000417	CcSEcCtD
Rabeprazole—Pruritus—Triamcinolone—multiple sclerosis	0.000119	0.000416	CcSEcCtD
Rabeprazole—Cough—Methotrexate—multiple sclerosis	0.000119	0.000415	CcSEcCtD
Rabeprazole—Pruritus—Methylprednisolone—multiple sclerosis	0.000119	0.000415	CcSEcCtD
Rabeprazole—Convulsion—Methotrexate—multiple sclerosis	0.000118	0.000412	CcSEcCtD
Rabeprazole—Dyspepsia—Prednisone—multiple sclerosis	0.000117	0.000409	CcSEcCtD
Rabeprazole—Arthralgia—Methotrexate—multiple sclerosis	0.000116	0.000405	CcSEcCtD
Rabeprazole—Chest pain—Methotrexate—multiple sclerosis	0.000116	0.000405	CcSEcCtD
Rabeprazole—Myalgia—Methotrexate—multiple sclerosis	0.000116	0.000405	CcSEcCtD
Rabeprazole—Decreased appetite—Prednisone—multiple sclerosis	0.000116	0.000404	CcSEcCtD
Rabeprazole—Rash—Prednisolone—multiple sclerosis	0.000115	0.000403	CcSEcCtD
Rabeprazole—Dermatitis—Prednisolone—multiple sclerosis	0.000115	0.000402	CcSEcCtD
Rabeprazole—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000115	0.000401	CcSEcCtD
Rabeprazole—Headache—Prednisolone—multiple sclerosis	0.000115	0.0004	CcSEcCtD
Rabeprazole—Discomfort—Methotrexate—multiple sclerosis	0.000114	0.0004	CcSEcCtD
Rabeprazole—Constipation—Prednisone—multiple sclerosis	0.000114	0.000397	CcSEcCtD
Rabeprazole—Confusional state—Methotrexate—multiple sclerosis	0.000112	0.000391	CcSEcCtD
Rabeprazole—Dizziness—Triamcinolone—multiple sclerosis	0.000111	0.000388	CcSEcCtD
Rabeprazole—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000111	0.000388	CcSEcCtD
Rabeprazole—Dizziness—Methylprednisolone—multiple sclerosis	0.000111	0.000388	CcSEcCtD
Rabeprazole—Feeling abnormal—Prednisone—multiple sclerosis	0.000109	0.000383	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000109	0.0182	CbGpPWpGaD
Rabeprazole—Asthenia—Betamethasone—multiple sclerosis	0.000109	0.000382	CcSEcCtD
Rabeprazole—Asthenia—Dexamethasone—multiple sclerosis	0.000109	0.000382	CcSEcCtD
Rabeprazole—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000109	0.00038	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000109	0.00038	CcSEcCtD
Rabeprazole—Nausea—Prednisolone—multiple sclerosis	0.000109	0.000379	CcSEcCtD
Rabeprazole—Pruritus—Dexamethasone—multiple sclerosis	0.000108	0.000377	CcSEcCtD
Rabeprazole—Pruritus—Betamethasone—multiple sclerosis	0.000108	0.000377	CcSEcCtD
Rabeprazole—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000107	0.000375	CcSEcCtD
Rabeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000107	0.0178	CbGpPWpGaD
Rabeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000107	0.0178	CbGpPWpGaD
Rabeprazole—Vomiting—Triamcinolone—multiple sclerosis	0.000107	0.000374	CcSEcCtD
Rabeprazole—Vomiting—Methylprednisolone—multiple sclerosis	0.000107	0.000373	CcSEcCtD
Rabeprazole—Rash—Triamcinolone—multiple sclerosis	0.000106	0.00037	CcSEcCtD
Rabeprazole—Dermatitis—Triamcinolone—multiple sclerosis	0.000106	0.00037	CcSEcCtD
Rabeprazole—Anorexia—Methotrexate—multiple sclerosis	0.000106	0.00037	CcSEcCtD
Rabeprazole—Rash—Methylprednisolone—multiple sclerosis	0.000106	0.00037	CcSEcCtD
Rabeprazole—Dermatitis—Methylprednisolone—multiple sclerosis	0.000106	0.000369	CcSEcCtD
Rabeprazole—Urticaria—Prednisone—multiple sclerosis	0.000106	0.000369	CcSEcCtD
Rabeprazole—Headache—Triamcinolone—multiple sclerosis	0.000105	0.000368	CcSEcCtD
Rabeprazole—Headache—Methylprednisolone—multiple sclerosis	0.000105	0.000367	CcSEcCtD
Rabeprazole—Abdominal pain—Prednisone—multiple sclerosis	0.000105	0.000367	CcSEcCtD
Rabeprazole—Body temperature increased—Prednisone—multiple sclerosis	0.000105	0.000367	CcSEcCtD
Rabeprazole—Diarrhoea—Dexamethasone—multiple sclerosis	0.000104	0.000365	CcSEcCtD
Rabeprazole—Diarrhoea—Betamethasone—multiple sclerosis	0.000104	0.000365	CcSEcCtD
Rabeprazole—Hypotension—Methotrexate—multiple sclerosis	0.000104	0.000363	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000101	0.000353	CcSEcCtD
Rabeprazole—Dizziness—Betamethasone—multiple sclerosis	0.000101	0.000352	CcSEcCtD
Rabeprazole—Dizziness—Dexamethasone—multiple sclerosis	0.000101	0.000352	CcSEcCtD
Rabeprazole—Insomnia—Methotrexate—multiple sclerosis	0.0001	0.000351	CcSEcCtD
Rabeprazole—Nausea—Triamcinolone—multiple sclerosis	9.99e-05	0.000349	CcSEcCtD
Rabeprazole—Paraesthesia—Methotrexate—multiple sclerosis	9.97e-05	0.000348	CcSEcCtD
Rabeprazole—Nausea—Methylprednisolone—multiple sclerosis	9.97e-05	0.000348	CcSEcCtD
Rabeprazole—Dyspnoea—Methotrexate—multiple sclerosis	9.9e-05	0.000346	CcSEcCtD
Rabeprazole—Somnolence—Methotrexate—multiple sclerosis	9.87e-05	0.000345	CcSEcCtD
Rabeprazole—Hypersensitivity—Prednisone—multiple sclerosis	9.79e-05	0.000342	CcSEcCtD
Rabeprazole—Dyspepsia—Methotrexate—multiple sclerosis	9.77e-05	0.000341	CcSEcCtD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.76e-05	0.0163	CbGpPWpGaD
Rabeprazole—Vomiting—Betamethasone—multiple sclerosis	9.7e-05	0.000339	CcSEcCtD
Rabeprazole—Vomiting—Dexamethasone—multiple sclerosis	9.7e-05	0.000339	CcSEcCtD
Rabeprazole—Decreased appetite—Methotrexate—multiple sclerosis	9.65e-05	0.000337	CcSEcCtD
Rabeprazole—Rash—Dexamethasone—multiple sclerosis	9.62e-05	0.000336	CcSEcCtD
Rabeprazole—Rash—Betamethasone—multiple sclerosis	9.62e-05	0.000336	CcSEcCtD
Rabeprazole—Dermatitis—Dexamethasone—multiple sclerosis	9.61e-05	0.000336	CcSEcCtD
Rabeprazole—Dermatitis—Betamethasone—multiple sclerosis	9.61e-05	0.000336	CcSEcCtD
Rabeprazole—Headache—Dexamethasone—multiple sclerosis	9.56e-05	0.000334	CcSEcCtD
Rabeprazole—Headache—Betamethasone—multiple sclerosis	9.56e-05	0.000334	CcSEcCtD
Rabeprazole—Asthenia—Prednisone—multiple sclerosis	9.53e-05	0.000333	CcSEcCtD
Rabeprazole—Pain—Methotrexate—multiple sclerosis	9.5e-05	0.000332	CcSEcCtD
Rabeprazole—Pruritus—Prednisone—multiple sclerosis	9.4e-05	0.000328	CcSEcCtD
Rabeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	9.16e-05	0.0153	CbGpPWpGaD
Rabeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	9.16e-05	0.0153	CbGpPWpGaD
Rabeprazole—Feeling abnormal—Methotrexate—multiple sclerosis	9.15e-05	0.00032	CcSEcCtD
Rabeprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	9.12e-05	0.0152	CbGpPWpGaD
Rabeprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	9.12e-05	0.0152	CbGpPWpGaD
Rabeprazole—Diarrhoea—Prednisone—multiple sclerosis	9.09e-05	0.000318	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.08e-05	0.000317	CcSEcCtD
Rabeprazole—Nausea—Betamethasone—multiple sclerosis	9.06e-05	0.000317	CcSEcCtD
Rabeprazole—Nausea—Dexamethasone—multiple sclerosis	9.06e-05	0.000317	CcSEcCtD
Rabeprazole—CYP1A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	9e-05	0.015	CbGpPWpGaD
Rabeprazole—CYP1A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	9e-05	0.015	CbGpPWpGaD
Rabeprazole—Urticaria—Methotrexate—multiple sclerosis	8.82e-05	0.000308	CcSEcCtD
Rabeprazole—Dizziness—Prednisone—multiple sclerosis	8.79e-05	0.000307	CcSEcCtD
Rabeprazole—Abdominal pain—Methotrexate—multiple sclerosis	8.78e-05	0.000307	CcSEcCtD
Rabeprazole—Body temperature increased—Methotrexate—multiple sclerosis	8.78e-05	0.000307	CcSEcCtD
Rabeprazole—Vomiting—Prednisone—multiple sclerosis	8.45e-05	0.000295	CcSEcCtD
Rabeprazole—Rash—Prednisone—multiple sclerosis	8.38e-05	0.000293	CcSEcCtD
Rabeprazole—Dermatitis—Prednisone—multiple sclerosis	8.37e-05	0.000292	CcSEcCtD
Rabeprazole—Headache—Prednisone—multiple sclerosis	8.32e-05	0.000291	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.3e-05	0.0138	CbGpPWpGaD
Rabeprazole—Hypersensitivity—Methotrexate—multiple sclerosis	8.18e-05	0.000286	CcSEcCtD
Rabeprazole—Asthenia—Methotrexate—multiple sclerosis	7.97e-05	0.000278	CcSEcCtD
Rabeprazole—Nausea—Prednisone—multiple sclerosis	7.89e-05	0.000276	CcSEcCtD
Rabeprazole—Pruritus—Methotrexate—multiple sclerosis	7.86e-05	0.000274	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	7.81e-05	0.013	CbGpPWpGaD
Rabeprazole—Diarrhoea—Methotrexate—multiple sclerosis	7.6e-05	0.000265	CcSEcCtD
Rabeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	7.46e-05	0.0124	CbGpPWpGaD
Rabeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	7.46e-05	0.0124	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.4e-05	0.0123	CbGpPWpGaD
Rabeprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	7.39e-05	0.0123	CbGpPWpGaD
Rabeprazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	7.39e-05	0.0123	CbGpPWpGaD
Rabeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	7.36e-05	0.0123	CbGpPWpGaD
Rabeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	7.36e-05	0.0123	CbGpPWpGaD
Rabeprazole—Dizziness—Methotrexate—multiple sclerosis	7.34e-05	0.000257	CcSEcCtD
Rabeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	7.07e-05	0.0118	CbGpPWpGaD
Rabeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	7.07e-05	0.0118	CbGpPWpGaD
Rabeprazole—Vomiting—Methotrexate—multiple sclerosis	7.06e-05	0.000247	CcSEcCtD
Rabeprazole—Rash—Methotrexate—multiple sclerosis	7e-05	0.000245	CcSEcCtD
Rabeprazole—Dermatitis—Methotrexate—multiple sclerosis	7e-05	0.000244	CcSEcCtD
Rabeprazole—Headache—Methotrexate—multiple sclerosis	6.96e-05	0.000243	CcSEcCtD
Rabeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	6.86e-05	0.0114	CbGpPWpGaD
Rabeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	6.86e-05	0.0114	CbGpPWpGaD
Rabeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	6.8e-05	0.0113	CbGpPWpGaD
Rabeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	6.8e-05	0.0113	CbGpPWpGaD
Rabeprazole—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	6.77e-05	0.0113	CbGpPWpGaD
Rabeprazole—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	6.77e-05	0.0113	CbGpPWpGaD
Rabeprazole—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	6.71e-05	0.0112	CbGpPWpGaD
Rabeprazole—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	6.71e-05	0.0112	CbGpPWpGaD
Rabeprazole—Nausea—Methotrexate—multiple sclerosis	6.6e-05	0.00023	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.56e-05	0.0109	CbGpPWpGaD
Rabeprazole—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	6.25e-05	0.0104	CbGpPWpGaD
Rabeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	6.05e-05	0.0101	CbGpPWpGaD
Rabeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	6.05e-05	0.0101	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.85e-05	0.00974	CbGpPWpGaD
Rabeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	5.81e-05	0.00968	CbGpPWpGaD
Rabeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	5.81e-05	0.00968	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.8e-05	0.00966	CbGpPWpGaD
Rabeprazole—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	5.74e-05	0.00956	CbGpPWpGaD
Rabeprazole—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	5.74e-05	0.00956	CbGpPWpGaD
Rabeprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	5.56e-05	0.00927	CbGpPWpGaD
Rabeprazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	5.56e-05	0.00927	CbGpPWpGaD
Rabeprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	5.51e-05	0.00919	CbGpPWpGaD
Rabeprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	5.51e-05	0.00919	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.17e-05	0.00861	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	4.98e-05	0.0083	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	4.91e-05	0.00818	CbGpPWpGaD
Rabeprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	4.71e-05	0.00785	CbGpPWpGaD
Rabeprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	4.71e-05	0.00785	CbGpPWpGaD
Rabeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	4.49e-05	0.00747	CbGpPWpGaD
Rabeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	4.49e-05	0.00747	CbGpPWpGaD
Rabeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	4.43e-05	0.00738	CbGpPWpGaD
Rabeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	4.43e-05	0.00738	CbGpPWpGaD
Rabeprazole—CYP1A1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	4.34e-05	0.00722	CbGpPWpGaD
Rabeprazole—CYP1A1—Melatonin metabolism and effects—APOE—multiple sclerosis	4.27e-05	0.00711	CbGpPWpGaD
Rabeprazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	4.02e-05	0.00671	CbGpPWpGaD
Rabeprazole—CYP1A1—Biological oxidations—CYP27B1—multiple sclerosis	3.93e-05	0.00654	CbGpPWpGaD
Rabeprazole—CYP1A1—Biological oxidations—CYP24A1—multiple sclerosis	3.93e-05	0.00654	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.87e-05	0.00645	CbGpPWpGaD
Rabeprazole—CYP1A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.87e-05	0.00645	CbGpPWpGaD
Rabeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	3.64e-05	0.00606	CbGpPWpGaD
Rabeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	3.64e-05	0.00606	CbGpPWpGaD
Rabeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	3.51e-05	0.00584	CbGpPWpGaD
Rabeprazole—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	3.49e-05	0.00582	CbGpPWpGaD
Rabeprazole—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	3.21e-05	0.00535	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	3.21e-05	0.00535	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	3.21e-05	0.00535	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.17e-05	0.00528	CbGpPWpGaD
Rabeprazole—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.17e-05	0.00528	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	3.13e-05	0.00521	CbGpPWpGaD
Rabeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	3e-05	0.00499	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	2.95e-05	0.00492	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	2.95e-05	0.00492	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	2.93e-05	0.00488	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	2.93e-05	0.00488	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.91e-05	0.00485	CbGpPWpGaD
Rabeprazole—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.91e-05	0.00485	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.89e-05	0.00481	CbGpPWpGaD
Rabeprazole—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.89e-05	0.00481	CbGpPWpGaD
Rabeprazole—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	2.76e-05	0.00461	CbGpPWpGaD
Rabeprazole—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	2.72e-05	0.00454	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	2.5e-05	0.00417	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	2.5e-05	0.00417	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.47e-05	0.00411	CbGpPWpGaD
Rabeprazole—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.47e-05	0.00411	CbGpPWpGaD
Rabeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	2.31e-05	0.00385	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.28e-05	0.00379	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	2.11e-05	0.00352	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.09e-05	0.00348	CbGpPWpGaD
Rabeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	2.06e-05	0.00343	CbGpPWpGaD
Rabeprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.05e-05	0.00342	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	1.93e-05	0.00322	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	1.93e-05	0.00322	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.91e-05	0.00317	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.91e-05	0.00317	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	1.88e-05	0.00314	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	1.87e-05	0.00312	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.86e-05	0.0031	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.73e-05	0.00288	CbGpPWpGaD
Rabeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.68e-05	0.0028	CbGpPWpGaD
Rabeprazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.66e-05	0.00277	CbGpPWpGaD
Rabeprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.54e-05	0.00257	CbGpPWpGaD
Rabeprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.53e-05	0.00255	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.51e-05	0.00251	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.51e-05	0.00251	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	1.47e-05	0.00244	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	1.46e-05	0.00244	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	1.43e-05	0.00239	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SRM—multiple sclerosis	1.41e-05	0.00235	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	1.37e-05	0.00228	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1.37e-05	0.00228	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.36e-05	0.00227	CbGpPWpGaD
Rabeprazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.36e-05	0.00227	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	1.35e-05	0.00224	CbGpPWpGaD
Rabeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.31e-05	0.00218	CbGpPWpGaD
Rabeprazole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.25e-05	0.00208	CbGpPWpGaD
Rabeprazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.24e-05	0.00207	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.23e-05	0.00206	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.23e-05	0.00206	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.21e-05	0.00201	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	1.2e-05	0.002	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	1.2e-05	0.00199	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.12e-05	0.00187	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.12e-05	0.00187	CbGpPWpGaD
Rabeprazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.06e-05	0.00177	CbGpPWpGaD
Rabeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.01e-05	0.00168	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP24A1—multiple sclerosis	9.92e-06	0.00165	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP27B1—multiple sclerosis	9.92e-06	0.00165	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.61e-06	0.0016	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.61e-06	0.0016	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SRM—multiple sclerosis	9.53e-06	0.00159	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	9.35e-06	0.00156	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	9.33e-06	0.00155	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	9.15e-06	0.00152	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GPC5—multiple sclerosis	9.07e-06	0.00151	CbGpPWpGaD
Rabeprazole—CYP1A1—Biological oxidations—POMC—multiple sclerosis	8.83e-06	0.00147	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	8.71e-06	0.00145	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	8.71e-06	0.00145	CbGpPWpGaD
Rabeprazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.18e-06	0.00136	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SRM—multiple sclerosis	7.8e-06	0.0013	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—RRM1—multiple sclerosis	7.52e-06	0.00125	CbGpPWpGaD
Rabeprazole—CYP2C19—Biological oxidations—POMC—multiple sclerosis	7.23e-06	0.0012	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SRM—multiple sclerosis	7.17e-06	0.00119	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SRM—multiple sclerosis	7.11e-06	0.00118	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	6.71e-06	0.00112	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	6.71e-06	0.00112	CbGpPWpGaD
Rabeprazole—CYP2D6—Biological oxidations—POMC—multiple sclerosis	6.65e-06	0.00111	CbGpPWpGaD
Rabeprazole—CYP2C9—Biological oxidations—POMC—multiple sclerosis	6.59e-06	0.0011	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.56e-06	0.00109	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GPC5—multiple sclerosis	6.14e-06	0.00102	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SRM—multiple sclerosis	6.08e-06	0.00101	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—POMC—multiple sclerosis	5.63e-06	0.000938	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	5.49e-06	0.000915	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	5.49e-06	0.000915	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.37e-06	0.000895	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—RRM1—multiple sclerosis	5.09e-06	0.000848	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	5.05e-06	0.000842	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	5.05e-06	0.000842	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GPC5—multiple sclerosis	5.02e-06	0.000837	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	5.01e-06	0.000835	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	5.01e-06	0.000835	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.9e-06	0.000816	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SRM—multiple sclerosis	4.69e-06	0.000781	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.62e-06	0.00077	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GPC5—multiple sclerosis	4.58e-06	0.000763	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.35e-06	0.000724	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.34e-06	0.000723	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—BCHE—multiple sclerosis	4.32e-06	0.000719	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	4.28e-06	0.000713	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	4.28e-06	0.000713	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.18e-06	0.000697	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—RRM1—multiple sclerosis	4.16e-06	0.000694	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.95e-06	0.000658	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.91e-06	0.000652	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.83e-06	0.000638	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—RRM1—multiple sclerosis	3.8e-06	0.000632	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.39e-06	0.000565	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.3e-06	0.00055	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.3e-06	0.00055	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—RRM1—multiple sclerosis	3.24e-06	0.00054	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.23e-06	0.000538	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.09e-06	0.000515	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.02e-06	0.000503	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.95e-06	0.000491	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—BCHE—multiple sclerosis	2.92e-06	0.000487	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.77e-06	0.000462	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—APOE—multiple sclerosis	2.6e-06	0.000433	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.53e-06	0.000422	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.53e-06	0.000421	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.52e-06	0.000419	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.5e-06	0.000417	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.39e-06	0.000398	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.31e-06	0.000384	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—POMC—multiple sclerosis	2.23e-06	0.000372	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.2e-06	0.000366	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.18e-06	0.000363	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.16e-06	0.00036	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALB—multiple sclerosis	2.03e-06	0.000339	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.97e-06	0.000328	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.86e-06	0.00031	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOE—multiple sclerosis	1.76e-06	0.000293	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—POMC—multiple sclerosis	1.51e-06	0.000252	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOE—multiple sclerosis	1.44e-06	0.00024	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.44e-06	0.00024	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALB—multiple sclerosis	1.38e-06	0.000229	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOE—multiple sclerosis	1.32e-06	0.00022	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOE—multiple sclerosis	1.31e-06	0.000219	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—POMC—multiple sclerosis	1.24e-06	0.000206	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—POMC—multiple sclerosis	1.14e-06	0.000189	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—POMC—multiple sclerosis	1.13e-06	0.000188	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALB—multiple sclerosis	1.13e-06	0.000188	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOE—multiple sclerosis	1.12e-06	0.000187	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALB—multiple sclerosis	1.04e-06	0.000173	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALB—multiple sclerosis	1.03e-06	0.000171	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—POMC—multiple sclerosis	9.63e-07	0.00016	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALB—multiple sclerosis	8.78e-07	0.000146	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOE—multiple sclerosis	8.65e-07	0.000144	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—POMC—multiple sclerosis	7.43e-07	0.000124	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALB—multiple sclerosis	6.77e-07	0.000113	CbGpPWpGaD
